Understanding autoimmune diseases through tissue analysis
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
This study is looking at tissue samples from people with autoimmune diseases like lupus and rheumatoid arthritis to better understand what’s happening at the cellular level, with the hope of finding new treatments and insights into these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11061264 on NIH RePORTER |
What this research studies
This research focuses on analyzing tissue samples from patients with autoimmune diseases such as lupus, rheumatoid arthritis, and Sjogren’s disease. By using advanced single-cell transcriptomic technologies, the project aims to uncover the cellular components and interactions that contribute to these conditions. Patients will provide high-quality samples that will be processed using standardized methods to ensure accurate results. The goal is to create a well-characterized cohort that can help in developing new treatments and understanding disease mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with autoimmune diseases like lupus, rheumatoid arthritis, Sjogren’s disease, or psoriatic spectrum diseases.
Not a fit: Patients with non-autoimmune conditions or those not diagnosed with the specified autoimmune diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-targeted therapies and improved outcomes for patients with autoimmune diseases.
How similar studies have performed: Previous research initiatives like the Accelerating Medicines Partnership in RA/Lupus have shown success in utilizing similar approaches to advance understanding of autoimmune diseases.
Where this research is happening
Oklahoma City, United States
- Oklahoma Medical Research Foundation — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Guthridge, Joel Marvin — Oklahoma Medical Research Foundation
- Study coordinator: Guthridge, Joel Marvin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.